Most Recent

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

image: Agar Shortage Limits Lab Supplies

Agar Shortage Limits Lab Supplies

By | November 24, 2015

One large provider says the shortfall should clear up by early 2016.

1 Comment

image: Opinion: Translation Nation

Opinion: Translation Nation

By | November 18, 2015

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

0 Comments

image: Clinical Trial Data Underreported: Study

Clinical Trial Data Underreported: Study

By | November 16, 2015

One-third of the human experiments for approved drugs failed transparency requirements.

0 Comments

image: Breaching the Blood-Brain Barrier

Breaching the Blood-Brain Barrier

By | November 11, 2015

Researchers deliver cancer-fighting drugs to a patient’s brain via the bloodstream, penetrating the blood-brain barrier for the first time.

0 Comments

image: Blood Cell Development Reimagined

Blood Cell Development Reimagined

By | November 9, 2015

A new study is rewriting 50 years of biological dogma by suggesting that mature blood cells develop much more rapidly from stem cells than previously thought.

0 Comments

image: Following the Funding

Following the Funding

By | November 4, 2015

Researchers use network theory to estimate the importance of relationships among researchers and institutions in attracting grant money.

0 Comments

image: Adding Padding

Adding Padding

By | November 1, 2015

Adipogenesis in mice has alternating genetic requirements throughout the animals’ lives.

0 Comments

image: Battling the Bulge

Battling the Bulge

By | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2015

The Psychology of Overeating, The Hidden Half of Nature, The Death of Cancer, and The Secret of Our Success

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech